BlueWhale Bio, Inc.
Last verified 2026-05-05. JSON
| Total raised | $5.0M |
|---|---|
| Latest round | Funding round, $5.0M, 2025-10-16 |
| Founded | unknown |
| Headquarters | PHILADELPHIA, PA |
| Industry | bio |
| Stage | unknown |
| Website | bluewhalebio.com |
Develops the Synecta cell-therapy manufacturing platform focused on activation and expansion of T cells. Sold to cell-therapy developers and CDMOs producing CAR-T and other immunotherapies. Spun out of Penn under Carl June and James Riley, backed by $18M from Danaher Ventures, Hillhouse and Marshall Wace.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-10-16 | Funding round | $5.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $5.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $5.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | bluewhalebio.com, read 2026-05-05 |
| Description | self-reported | bluewhalebio.com, read 2026-05-05 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $5.0M, 2025-10-16 → Funding round, $5.0M, 2025-10-16, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $5.0M, 2025-10-16 → Funding round, $5.0M, 2025-10-16 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes